Form 4: IMAX CEO Richard Gelfond Executes Stock Option Plan

IMAX CEO Richard Gelfond exercised stock options and sold the resulting common shares under a pre-arranged 10b5-1 trading plan.

Summary

• CEO Richard Gelfond exercised 75,919 stock options in total across two days, April 16 and April 17, 2026.
• The options were exercised at a strike price of $31.40 per share.
• The resulting common shares were sold immediately at market prices ranging from $37.0496 to $37.0572 per share.
• The transactions were executed pursuant to a Rule 10b5-1 trading plan established on December 9, 2025.
• Following these transactions, the CEO maintains a direct ownership of 765,002 common shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transactions were pre-planned and represent routine liquidity management by the CEO.

Positives

• Transactions were conducted under a pre-established 10b5-1 plan, indicating a systematic approach to liquidity rather than reactive selling.
• The CEO retains a significant equity stake of 765,002 common shares, 231,562 restricted share units, and 1,341,354 options.

Negatives

• The sale of shares by a top executive can sometimes be perceived by the market as a lack of confidence in future price appreciation, though this was pre-planned.

Risks

• The options exercised were set to expire on June 7, 2026, necessitating action to capture value before expiration.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing, as it is a standard disclosure of insider transaction activity.

Management Comments

• The transactions were executed pursuant to a 10b5-1 plan dated December 9, 2025.

Industry Context

StockSavvy.ai notes that executive stock sales under 10b5-1 plans are common practice for liquidity and tax planning, particularly as options approach their expiration dates, and generally do not signal a change in corporate strategy.

Comparison to Industry Standards

• The use of 10b5-1 plans is the industry standard for executives to sell shares while avoiding potential insider trading allegations.
• The timing of the exercise aligns with the impending June 2026 expiration of the 2016-issued options.

Stakeholder Impact

• Minimal impact on shareholders as the transactions were pre-planned and executed at market rates.

Next Steps

• No further actions mentioned beyond the completion of the reported transactions.

Key Dates

Keywords

IMAX, Insider Trading, Form 4, Richard Gelfond, Stock Options, 10b5-1 Plan